-
Fortune | The FDA announced its approval of a Theranos test for the sexually transmitted disease herpes simplex virus (HSV-1) and--more importantly--approval for the Theranos platform.
Jul 2, 2015
-
Xconomy | Natera's IPO is looming, with the offering coming as early as tonight. Xconomy reports that in documents filed today with the SEC, the company raised its fundraising goal to $175 million. The company hopes to sell 10 million shares at $17-$18 each.
Jul 1, 2015
-
Diagnostics World Brief | In a new market report released this morning, BCC Research predicts the next-generation sequencing (NGS) clinical market could grow at a compound annual growth rate of 31.3% from $997.1m in 2015 to nearly $3.9b by 2020.
Jul 1, 2015
-
Technology Review | Eventually, the most important use of liquid biopsies should be to catch signs of cancer early, before symptoms arise—when a surgeon can cure it by cutting it out. Such screening could profoundly reshape cancer medicine. For now, though, they are being used as “theragnostics”—that is, tests that guide decisions about treatment.
Jun 25, 2015
-
Diagnostics World | Color Genomics is just one of several companies toying with a new model for selling low-priced DNA tests online, by enlisting physicians as intermediaries. If Color's business model becomes popular, it will have big implications for the way genomic testing reaches the broader public — and who sets the standards for this maturing technology.
Jun 22, 2015
-
Diagnostics World Brief | Foundation Medicine has launched PatientMatch, a tool to connect doctors who are treating patients with similar rare genetic mutations. At Sarah Cannon Research Institute, physicians are finding it useful for connecting patients to the right drug trials as well.
Jun 22, 2015
-
Diagnostics World Brief | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
Jun 22, 2015
-
Diagnostics World Brief | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
Jun 22, 2015
-
Diagnostics World Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
Jun 22, 2015
-
Diagnostics World Brief | Strand Life Sciences announced an expanded StrandAdvantage pan cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies.
Jun 1, 2015
-
By Bio IT World Staff March 30, 2015 | The New York Genome Center (NYGC) announced today that it has received approval from the New York State Department of Health to offer clinical whole exome sequencing for individuals with constitutional disorders.
May 27, 2015
-
By Bio IT World Staff April 13, 2015 | Roche is at it again. The pharma today acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening
May 27, 2015
-
May 14, 2015 | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long
May 27, 2015
-
By Bio IT World Staff May 27, 2015 | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next
May 27, 2015
-
February 19, 2015 | The Molecular Medicine Tri Conference is being held in San Francisco this week, and several updates and new products have emerged already. For live coverage of the event, follow @BioITWorld and the hashtag #TriCon on Twitter. Maverix
May 27, 2015
-
By Aaron Krol February 27, 2015 | Last week offered some brief sanctuary from snowy, subzero New England asBio IT World hit the 22nd annual Molecular Medicine Tri Conference in San Francisco, joining dozens of other Boston area professionals who navigated the ever
May 27, 2015
-
By Allison Proffitt May 21, 2015 | The CLARITY challenge is back, and calling for entries. Boston Children’s Hospital is launching the second iteration of the challenge—CLARITY Undiagnosed—focusing on identifying molecular diagnoses for five families with as yet undiagnosed conditions. Teams
May 27, 2015
-
January 28, 2015 | Cambridge, MA based Exosome Diagnostics aims to raise $25 million, on top of the $27 million in Series B funding it raised last March. Exosome would use the cash to launch its first two products a blood
May 27, 2015